in vivo-jetPEI™ transfection reagent for nucleic acid delivery is now available manufactured in full compliance with Good Manufacturing Practice (GMP), as required for clinical trials. A Drug Master File (DMF) describing the production of in vivo-jetPEI™ has been filed with the FDA, thus simplifying the documentation required for clinical trial applications. in vivo-jetPEI™ thus offers the possibility of using the same nucleic acid delivery reagent from early stages of preclinical research in animal models to clinical trials in humans.
GMP compliant in vivo-jetPEI™ transfection reagent
1251 Ave of the Americas, 34th fl. New York, NY 10020 Customer Service: (508) 315-9629 Tech Support: Fax Number: Web Site: http://www.polyplus-transfection.com/EN/index.php
View the latest short animated film from BINDER on their KBF series constant climate chambers... watch video
Recently, I investigated the possibility of a novel fusion protein in lung tumors... read more
Stay updated on the latest technologies and news with Biocompare's newsletters (See samples here)